Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

intervet international b.v. - clostridium perfringens type a (alfa) toxoid >= 0,5 iu/ml; clostridium sordellii toxoïd >= 4,4 u/ml; clostridium perfringens type d (epsilon) toxoid >= 5,3 iu/ml; clostridium septicum toxoid >= 4,6 iu/ml; clostridium novyi toxoid >= 3,8 iu/ml; clostridium perfringens, type b and c, beta toxoid >= 18,2 iu/dose; clostridium haemolyticum toxoid >= 17,4 u/ml; clostridium chauvoei (inactivated) ; clostridium tetani toxoid >= 4,9 iu/ml - suspension for injection - clostridium novyi toxoid; clostridium tetani toxoid; clostridium haemolyticum toxoid; clostridium sordellii toxoid; clostridium perfringens type a, α toxoid; clostridium perfringens type b,c (beta) toxoid; clostridium perfringens type d (epsilon) toxoid; clostridium chauvoei; clostridium septicum - clostridium; qi04ab01 clostridium - cattle; sheep

Ireland - English - HPRA (Health Products Regulatory Authority)

intervet ireland limited - clostridium perfringens type a, alfa toxoid; clostridium perfringens type b, beta toxoid; clostridium perfringens type c, beta toxoid; clostridium perfringens type d, epsilon toxoid; clostridium chauvoei, inactivated; clostridium novyi toxoid; clostridium septicum toxoid; clostridium tetani toxoid; clostridium sordellii toxoid; clostridium haemolyticum, toxoid - suspension for injection - . - clostridium

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

anaculture of clostridium chauvoei 100 % , toxoid of clostridium sordelli 100 % , toxoid of clostridium tetani 2.5 iu , alpha toxoid of clostridium novyi type b 3.5 iu , alpha toxoid of clostridum septicum 2.5 iu , epsilon toxoid of clostridium perfringens type b and d , 5 , iu , beta toxoid of clostridium perfringens type b and c , 10 , iu , alpha toxoid of clostridum perfringens type a 0.3 , iu - suspension for injection

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

intervet australia pty limited - clostridium perfringens type a alpha toxoid - unknown - clostridium perfringens type a alpha toxoid vaccine active 0.0 - active constituent

European Union - English - EMA (European Medicines Agency)

ceva santé animale - clostridium perfringens type c, beta1 toxoid / clostridium perfringens, type a, alpha toxoid / clostridium perfringens, type a, beta2 toxoid / escherichia coli, fimbrial adhesin f4ab / escherichia coli, fimbrial adhesin f4ac / escherichia coli, fimbrial adhesin f5 / escherichia coli, fimbrial adhesin f6 - immunologicals for suidae, inactivated bacterial vaccines (including mycoplasma, toxoid and chlamydia) escherichia + clostridium - pigs - for the passive immunisation of progeny by active immunisation of pregnant sows and gilts to reduce:-           clinical signs (severe diarrhoea) and mortality caused by escherichia coli strains expressing the fimbrial adhesins f4ab, f4ac, f5 and f6-           clinical signs (diarrhoea during the first days of life) associated with clostridium perfringens type a expressing alpha and beta 2 toxins-           clinical signs and mortality associated with haemorrhagic and necrotising enteritis caused by clostridium perfringens type c expressing beta1 toxin

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

virbac (australia) pty ltd - clostridium perfringens type d toxoid - unknown - clostridium perfringens type d toxoid vaccine-toxoid active 0.0 - active constituent

European Union - English - EMA (European Medicines Agency)

intervet international bv - clostridium-perfringens-type-a alpha toxoid - immunologicals for aves - chicken - for the active immunisation of chickens to provide passive immunisation against necrotic enteritis to their progeny, during the laying period.to reduce mortality and the incidence and severity of lesions caused by clostridium-perfringens-type-a-induced necrotic enteritis. efficacy was demonstrated by challenge of chicks approximately three weeks after hatching.the onset of passive transfer of immunity: 6 weeks following completion of the vaccination procedure.the duration of passive transfer of immunity: 51 weeks following completion of the vaccination procedure.

European Union - English - EMA (European Medicines Agency)

laboratorios hipra, s.a. - clostridioides difficile toxoid a, clostridioides difficile toxoid b, clostridium perfringens, type a, alpha toxoid - immunologicals for suidae, inactivated bacterial vaccines for pigs, clostridium - pigs - for the passive immunisation of neonatal piglets by means of the active immunisation of breeding sows and gilts:- to prevent mortality and reduce clinical signs and macroscopic lesions caused by clostridioides difficile toxins a and b.- to reduce clinical signs and macroscopic lesions caused by clostridium perfringens type a, alpha toxin.

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

intervet australia pty limited - clostridium haemolyticum; clostridium perfringens type b toxoid; clostridium perfringens type c toxoid; clostridium chauvoei whole cell culture; clostridium novyi tybe b toxiod and inactivated cells; clostridium perfringens type d toxoid; clostridium septicum - toxoid; clostridium tetani - toxoid; thiomersal; aluminium (adjuvant) - misc. vaccines or anti sera - clostridium haemolyticum vaccine-toxoid active 21.2 tcp u/ml; clostridium perfringens type b toxoid vaccine-toxoid active 30.6 tcp u/ml; clostridium perfringens type c toxoid vaccine-toxoid active 15.3 tcp u/ml; clostridium chauvoei whole cell culture vaccine-microbial active 30.0 %ferm/ml; clostridium novyi tybe b toxiod and inactivated cells vaccine-toxiod active 5.95 tcp u/ml; clostridium perfringens type d toxoid vaccine-toxoid active 55.3 tcp u/ml; clostridium septicum - toxoid vaccine-toxoid active 6.4 tcp u/ml; clostridium tetani - toxoid vaccine-toxoid active 3.0 lf u/ml; thiomersal mercury other 0.15 mg/ml; aluminium (adjuvant) mineral-aluminium other 0.0 mg/ml - immunotherapy - cattle | lamb | sheep | beef | bos indicus | bos taurus | bovine | buffalo | bull | bullock | calf | cow | dairy cow | ewe | hei - black disease | blackleg | dysentery | enterotoxaemia (pulpy kidney) | haemorrhagic enterotoxaemia | malignant oedema | post parturient gangrene | swelled head | tetanus | tick fever - bovine babesiosis | babesia bigemina | babesia bovis | clostridium perfringens type d | red water | redwater | tetanus vaccination

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

virbac (australia) pty ltd - clostridium perfringens type d toxoid; clostridium tetani - toxoid; corynebacterium pseudotuberculosis - toxoid; thiomersal - misc. vaccines or anti sera - clostridium perfringens type d toxoid vaccine-toxoid active 5.0 iu/ml; clostridium tetani - toxoid vaccine-toxoid active 2.5 iu/ml; corynebacterium pseudotuberculosis - toxoid vaccine-toxoid active 1.0 iu/ml; thiomersal mercury other 0.13 g/l - immunotherapy - lamb | sheep | ewe | hogget | lamb | ovine | ram | weaner | wether - cheesy gland | enterotoxaemia (pulpy kidney) | tetanus | clostridium perfringens type d | lymphadenitis | lymphangitis | tetanus vaccination